OmniAb, Inc. (OABI)
4.905
-0.04
(-0.91%)
USD |
NASDAQ |
Nov 13, 16:00
4.905
0.00 (0.00%)
After-Hours: 19:59
OmniAb Price : 4.905 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 5.065 | 5.08 | 4.73 | 4.95 | 1.403M |
| Nov 11, 2026 | 5.10 | 5.20 | 5.035 | 5.10 | 789374.0 |
| Nov 10, 2026 | 5.25 | 5.35 | 4.855 | 5.10 | 1.754M |
| Nov 09, 2026 | 5.12 | 5.45 | 5.01 | 5.30 | 2.474M |
| Nov 06, 2026 | 4.86 | 5.215 | 4.86 | 5.03 | 1.443M |
| Nov 05, 2026 | 5.18 | 5.21 | 4.795 | 4.83 | 1.247M |
| Nov 04, 2026 | 5.285 | 5.36 | 4.99 | 5.18 | 1.142M |
| Nov 03, 2026 | 5.12 | 5.37 | 5.015 | 5.15 | 1.575M |
| Nov 02, 2026 | 5.11 | 5.31 | 4.935 | 5.09 | 2.149M |
| Oct 30, 2026 | 4.40 | 5.11 | 4.35 | 5.11 | 2.114M |
| Oct 29, 2026 | 5.35 | 5.405 | 5.14 | 5.23 | 1.684M |
| Oct 28, 2026 | 4.92 | 5.29 | 4.905 | 5.28 | 1.584M |
| Oct 27, 2026 | 4.61 | 4.98 | 4.549 | 4.96 | 1.113M |
| Oct 26, 2026 | 4.66 | 4.72 | 4.53 | 4.61 | 971630.0 |
| Oct 23, 2026 | 4.70 | 4.785 | 4.515 | 4.66 | 1.283M |
| Oct 22, 2026 | 4.91 | 5.055 | 4.71 | 4.78 | 1.337M |
| Oct 21, 2026 | 4.96 | 5.132 | 4.80 | 4.915 | 3.176M |
| Oct 20, 2026 | 4.74 | 5.105 | 4.74 | 4.96 | 1.931M |
| Oct 19, 2026 | 4.53 | 4.755 | 4.52 | 4.69 | 892406.0 |
| Oct 16, 2026 | 4.73 | 4.82 | 4.505 | 4.59 | 969609.0 |
| Oct 15, 2026 | 4.60 | 4.755 | 4.531 | 4.73 | 820688.0 |
| Oct 14, 2026 | 4.62 | 4.83 | 4.530 | 4.55 | 737808.0 |
| Oct 13, 2026 | 4.76 | 4.815 | 4.620 | 4.70 | 809483.0 |
| Oct 12, 2026 | 4.77 | 4.845 | 4.64 | 4.77 | 988625.0 |
| Oct 09, 2026 | 4.66 | 4.915 | 4.59 | 4.79 | 1.039M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| IQVIA Holdings, Inc. | 264.97 |
| Champions Oncology, Inc. | 4.68 |
| Medpace Holdings, Inc. | 653.62 |
| Charles River Laboratories International, Inc. | 340.41 |
| Avantor, Inc. | 15.53 |
Price Related Metrics
| PS Ratio | 15.68 |
| Price to Book Value | 2.871 |
| Price to Free Cash Flow | 264.89 |
| Earnings Yield | -6.89% |
| Market Cap | 715.42M |